The role of group B coxsackieviruses (CVB) in the pathogenesis of type 1 diabetes mellitus (T1DM) remains controversial. A recent report by Stone et al. showed that a CVB1-based vaccine can protect against both CVB1 infection and CVB1-induced T1DM in mouse models. This tool could help to elucidate the relationship between CVB and T1DM.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023)
Wiener klinische Wochenschrift Open Access 01 January 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hober, D. & Sauter, P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6, 279–289 (2010).
Hober, D. & Alidjinou, E. K. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr. Opin. Infect. Dis. 26, 263–269 (2013).
Stone, V. M. et al. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 61, 476–481 (2018).
Drescher, K. M., von Herrath, M. & Tracy, S. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine. Rev. Med. Virol. 25, 19–32 (2015).
Krogvold, L. et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64, 1682–1687 (2015).
Yeung, W.-C. G., Rawlinson, W. D. & Craig, M. E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342, d35 (2011).
Op de Beeck, A. & Eizirik, D. L. Viral infections in type 1 diabetes mellitus — why the β cells? Nat. Rev. Endocrinol. 12, 263–273 (2016).
Morgan, N. G. & Richardson, S. J. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol. Metab. 25, 611–619 (2014).
Flodström, M. et al. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3, 373–382 (2002).
Hyöty, H. & Knip, M. Developing a vaccine for type 1 diabetes through targeting enteroviral infections. Expert Rev. Vaccines 13, 989–999 (2014).
Acknowledgements
The authors thank their team and all their collaborators.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Hober, D., Alidjinou, E. Towards a coxsackievirus B-based vaccine to combat T1DM. Nat Rev Endocrinol 14, 131–132 (2018). https://doi.org/10.1038/nrendo.2017.184
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2017.184
This article is cited by
-
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023)
Wiener klinische Wochenschrift (2023)
-
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
Nature Reviews Endocrinology (2022)
-
Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation
Virologica Sinica (2021)
-
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019)
Wiener klinische Wochenschrift (2019)